This process is essential for determining your prognosis and developing an appropriate treatment plan. There are three stages of multiple myeloma. Each stage can cause different symptoms and ...

Although the treatment of myeloma has changed dramatically after the readout of many recent trials, key unanswered questions ...

Some people with multiple myeloma have chromosomal abnormalities that make the disease more aggressive and resistant to treatment. Multiple myeloma is not hereditary, meaning genetic mutations ...

Saad Usmani, Chief of MSK's Myeloma Service, says there are far more treatment options for multiple myeloma today compared with just 20 years ago. Note: This story was originally published in 2022 and ...

Pomalyst (pomalidomide) is a prescription drug that’s used to treat multiple myeloma in adults. Pomalyst is also available as a generic drug. Pomalyst comes as an oral capsule. The active ...

Looking at the genetic makeup of multiple myeloma cells can help in deciding how aggressive treatment should be and what therapy to take. A fluorescence in situ hybridization test (FISH) is one of the ...

With current treatment advances in multiple myeloma, people are living with the disease longer than ever before. However, in order to maintain quality of life, the long term side effects of multiple ...

Despite being the second most common haematologic cancer globally, treatment options for multiple myeloma remain limited, with a significant need for new therapies. 1 Multiple myeloma originates i ...

Paris: Sanofi has announced that the Ministry of Health, Labour and Welfare (MHLW) in Japan has approved Sarclisa, in ...

Chimeric antigen receptor T-cell (CAR-T) therapy has ushered in a new era for the treatment of multiple myeloma (MM). Numerous clinical studies, especially those involving B-cell maturation antigen ...